Validation of the Maryland Aggregate Pathology Index (MAPI), a pre-implantation scoring system that predicts graft outcome

Clinical Transplantation

Volumn 28, Issue 8, 2014, Pages 897-905

  Philosophe, Benjamin ^a   Malat, Gregory E ^b   Soundararajan, Sunganthi ^b   Barth, Rolf N ^c   Manitpisikul, Wana ^d   Wilson, Nikita S ^d   Ranganna, Karthik ^b,c   Drachenberg, Cinthia B ^c   Papadimitriou, John C ^c   Neuman, Brian P ^a   Munivenkatappa, Raghava B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Deceased donor kidneys; Kidney scoring; Marginal donors; Suboptimal organs

Indexed keywords

CLINICAL TRIAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PRENATAL DIAGNOSIS; PROCEDURES; PROGNOSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; VALIDATION STUDY;

FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MARYLAND; MIDDLE AGED; PATIENT SELECTION; PREIMPLANTATION DIAGNOSIS; PROGNOSIS; RISK FACTORS;

EID: 84905564764     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12400     Document Type: Article

References (41)

1. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004: 4: 1289.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004: 4: 378.
3. Danovitch GM, Cohen DJ, Weir MR et al. Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 2005: 5(4 Pt 2): 904.
4. Gill JS, Rose C, Pereira BJ, Tonelli M. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007: 71: 442.
5. Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 2001: 12: 1293.
6. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol 2009: 4: 1239.
7. Hariharan S, McBride MA, Bennett LE, Cohen EP. Risk factors for renal allograft survival from older cadaver donors. Transplantation 1997: 64: 1748.
8. Matas AJ, Gillingham KJ, Elick BA et al. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 1997: 11: 259.
9. Matas AJ, Gillingham KJ, Humar A, Dunn DL, Sutherland DE, Najarian JS. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000: 69: 54.
10. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999: 13: 266.
11. Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999: 354: 1147.
12. Ojo AO, Leichtman AB, Punch JD et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000: 36: 153.
13. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI. Delayed graft function after renal transplantation. Transplantation 1998: 65: 219.
14. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplant 1997: 11(5 Pt 1): 366.
15. Tullius SG, Reutzel-Selke A, Egermann F et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol 2000: 11: 1317.
16. Dahmane D, Audard V, Hiesse C et al. Retrospective follow-up of transplantation of kidneys from 'marginal' donors. Kidney Int 2006: 69: 546.
17. Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002: 74: 1281.
18. Alsaad KO, Herzenberg AM. Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol 2007: 60: 18.
19. Smith JP. Hyaline arteriolosclerosis in the kidney. J Pathol Bacteriol 1955: 69: 147.
20. Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO. Organ donation and utilization in the United States, 1999-2008. Am J Transplant 2010: 10(4 Pt 2): 973.
21. Munivenkatappa RB, Schweitzer EJ, Papadimitriou JC et al. The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant 2008: 8: 2316.
22. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999: 130: 461.
24. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000: 56: 337.
25. Remuzzi G, Cravedi P, Perna A et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006: 354: 343.
26. Lehtonen SR, Taskinen EI, Isoniemi HM. Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function. APMIS 1999: 107: 945.
27. Lopes JA, Moreso F, Riera L et al. Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach. Kidney Int 2005: 67: 1595.
28. Snoeijs MG, Buurman WA, Christiaans MH et al. Histological assessment of preimplantation biopsies may improve selection of kidneys from old donors after cardiac death. Am J Transplant 2008: 8: 1844.
29. Nyberg SL, Matas AJ, Kremers WK et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant 2003: 3: 715.
30. Escofet X, Osman H, Griffiths DF, Woydag S, Adam Jurewicz W. The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantation. Transplantation 2003: 75: 344.
31. Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 1995: 60: 334.
32. Bajwa M, Cho YW, Pham PT et al. Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 2007: 84: 1399.
33. Cockfield SM, Moore RB, Todd G, Solez K, Gourishankar S. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation. Transplantation 2010: 89: 559.
34. Pokorna E, Vitko S, Chadimova M, Schuck O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000: 69: 36.
35. Sung RS, Christensen LL, Leichtman AB et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant 2008: 8: 783.
36. Bennett WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 1996: 34: 515.
37. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991: 2(2 Suppl 1): S45.
38. Wang HJ, Kjellstrand CM, Cockfield SM, Solez K. On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant 1998: 13: 165.
39. Bosmans JL, Ysebaert DK, Verpooten GA. Chronic allograft nephropathy: what have we learned from protocol biopsies? Transplantation 2008: 85(7 Suppl): S38.
40. Dart AB, Schall A, Gibson IW, Blydt-Hansen TD, Birk PE. Patterns of chronic injury in pediatric renal allografts. Transplantation 2010: 89: 334.
41. Kanzelmeyer NK, Ahlenstiel T, Drube J et al. Protocol biopsy-driven interventions after pediatric renal transplantation. Pediatr Transplant 2010: 14: 1012.